Mind Medicine (MindMed) Inc. (MNMD) Just Got Our Attention – News Heater
Home  »  Hot Stocks   »  Mind Medicine (MindMed) Inc. (MNMD) Just Got Our A...

Mind Medicine (MindMed) Inc. (MNMD) Just Got Our Attention

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) went down by -6.33% from its latest closing price compared to the recent 1-year high of $3.92. The company’s stock price has collected -13.63% of loss in the last five trading sessions.

Is It Worth Investing in Mind Medicine (MindMed) Inc. (NASDAQ :MNMD) Right Now?

Opinions of the stock are interesting as 5 analysts out of 5 who provided ratings for Mind Medicine (MindMed) Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $5.69. MNMD currently public float of 371.77M and currently shorts hold a 8.67% ratio of that float. Today, the average trading volume of MNMD was 2.55M shares.

MNMD’s Market Performance

MNMD stocks went down by -13.63% for the week, with a monthly drop of -13.28% and a quarterly performance of -45.63%, while its annual performance rate touched -81.37%. The volatility ratio for the week stands at 8.04% while the volatility levels for the past 30 days are set at 7.99% for Mind Medicine (MindMed) Inc. The simple moving average for the period of the last 20 days is -20.68% for MNMD stocks with a simple moving average of -55.79% for the last 200 days.

Analysts’ Opinion of MNMD

Many brokerage firms have already submitted their reports for MNMD stocks, with ROTH Capital repeating the rating for MNMD by listing it as a “Buy.” The predicted price for MNMD in the upcoming period, according to ROTH Capital is $7 based on the research report published on May 04th of the current year 2022.

Maxim Group, on the other hand, stated in their research note that they expect to see MNMD reach a price target of $6. The rating they have provided for MNMD stocks is “Buy” according to the report published on June 28th, 2021.

MNMD Trading at -20.86% from the 50-Day Moving Average

After a stumble in the market that brought MNMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.94% of loss for the given period.

Volatility was left at 7.99%, however, over the last 30 days, the volatility rate increased by 8.04%, as shares sank -15.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.02% lower at present.

During the last 5 trading sessions, MNMD fell by -13.63%, which changed the moving average for the period of 200-days by -76.54% in comparison to the 20-day moving average, which settled at $0.8370. In addition, Mind Medicine (MindMed) Inc. saw -51.54% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at MNMD starting from Barrow Robert, who sale 21,275 shares at the price of $0.70 back on Jun 16. After this action, Barrow Robert now owns 3,955,619 shares of Mind Medicine (MindMed) Inc., valued at $14,892 using the latest closing price.

Karlin Dan, the Chief Medical Officer of Mind Medicine (MindMed) Inc., sale 9,555 shares at $0.82 during a trade that took place back on May 27, which means that Karlin Dan is holding 4,077,719 shares at $7,835 based on the most recent closing price.

Stock Fundamentals for MNMD

The liquidity ratio also appears to be rather interesting for investors as it stands at 13.18.

Is Kimberly-Clark Corporation (KMB) a Keeper?

Kimberly-Clark Corporation (NYSE:KMB) went up by 3.54% from its latest closing price compared to the recent 1-year high of $145.79. The company’s stock price has